Stock HUMA HUMACYTE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Humacyte, Inc.

Equities

HUMA

US44486Q1031

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
7.27 USD -0.68% Intraday chart for Humacyte, Inc. -2.81% +155.99%
Jun. 03 Humacyte Insider Sold Shares Worth $1,561,605, According to a Recent SEC Filing MT
May. 30 Certain Common Stock of Humacyte, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Humacyte Insider Sold Shares Worth $1,561,605, According to a Recent SEC Filing
MT
Humacyte to Present at the Jefferies Global Healthcare Conference
AQ
Certain Common Stock of Humacyte, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024.
CI
Certain Warrants of Humacyte, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024.
CI
Certain Stock Options of Humacyte, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024.
CI
Humacyte First Quarter 2024 Financial Results and Business Update
AQ
Humacyte to Participate at Upcoming Investor Conferences in May
AQ
Transcript : Humacyte, Inc., Q1 2024 Earnings Call, May 10, 2024
Humacyte First Quarter 2024 Financial Results and Business Update
AQ
Humacyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 10, 2024
AQ
Transcript : Humacyte, Inc. - Special Call
Humacyte to Host Virtual KOL Event Hemodialysis Access, a Crossroads of Care, on March 28, 2024
AQ
Humacyte to Host Virtual KOL Event “Hemodialysis Access: A Crossroads of Care,” on March 28, 2024
AQ
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
AQ
Transcript : Humacyte, Inc., Q4 2023 Earnings Call, Mar 22, 2024
Interest Rate, Monetary Policy Views Lift Wall Street Pre-Bell; Asia Mixed, Europe Up
MT
Humacyte, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Humacyte Fourth Quarter and Year End 2023 Financial Results and Business Update
AQ
Humacyte, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HUMA Stock
  4. News Humacyte, Inc.